MED MEDIFAST INC
Miscellaneous Food Preparations & Kindred Products · NYSE · SEC CIK 910329 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-30.3%
TTM net income YoY-16,572.6%
TTM EPS YoY-18,600.0%
Revenue 3-yr CAGR-37.4%
Net income 3-yr CAGR—
Margins
Gross margin69.2%
Operating margin-11.6%
Net margin-13.6%
FCF margin-1.3%
EBITDA margin-7.4%
Returns
ROE-20.7%
ROA-16.1%
ROIC (approx.)-23.2%
Asset turnover1.18x
Leverage & solvency
Liabilities / assets24.8%
Debt / equity0.00x
Current ratio4.82x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.00x
Accruals ratio-16.1%
Payout ratio—
Capex / revenue1.3%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $72.05M | $76.38M | $76.04M | $75.10M | $89.41M | $105.56M | $115.73M | $119.00M |
| Cost of revenue | $22.01M | $22.99M | $24.29M | $22.96M | $27.25M | $28.91M | $31.48M | $30.78M |
| Gross profit | $50.04M | $53.40M | $51.76M | $52.14M | $62.16M | $76.64M | $84.25M | $88.22M |
| SG&A expense | $69.40M | $57.72M | $55.05M | $59.94M | $66.24M | $77.71M | $85.51M | $87.51M |
| Operating income | -$19.36M | -$4.33M | -$3.29M | -$7.80M | -$4.08M | -$1.07M | -$1.26M | $709,000 |
| Pretax income | -$17.84M | -$2.99M | -$1.94M | -$6.38M | -$2.66M | $2.88M | $526,000 | $1.27M |
| Income tax | -$324,000 | $109,000 | $181,000 | $11.74M | -$396,000 | $395,000 | $1.30M | $474,000 |
| Net income | -$17.51M | -$3.10M | -$2.12M | -$18.12M | -$2.26M | $2.48M | -$772,000 | $801,000 |
| EBITDA | -$17.00M | -$881,000 | $188,000 | -$4.34M | -$629,000 | $2.98M | $2.02M | $3.89M |
| EPS (basic) | -1.57 | -0.28 | -0.19 | — | -0.21 | 0.23 | -0.07 | — |
| EPS (diluted) | -1.57 | -0.28 | -0.19 | — | -0.21 | 0.22 | -0.07 | — |
| Dividends declared per share | — | — | — | — | — | — | — | 0.00 |
| Weighted avg. shares (diluted) | 11.18M | 11.13M | 11.01M | — | 10.99M | 11.06M | 10.95M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $58.37M | $71.91M | $71.53M | $89.30M | $99.53M | $101.69M | $91.72M | $90.93M |
| Short-term investments | $114.16M | $97.91M | $97.42M | $77.97M | $73.99M | $60.98M | $72.88M | $71.42M |
| Inventory | $21.20M | $21.18M | $21.40M | $20.23M | $23.20M | $30.20M | $39.36M | $42.42M |
| Current assets | $201.94M | $202.03M | $202.63M | $201.68M | $207.84M | $206.44M | $213.52M | $214.40M |
| PP&E, net | $13.24M | $27.98M | $29.64M | $31.23M | $32.85M | $34.60M | $36.31M | $37.53M |
| Total assets | $239.76M | $260.40M | $252.05M | $247.97M | $268.21M | $269.33M | $280.01M | $284.21M |
| Current liabilities | $41.88M | $41.56M | $42.18M | $42.96M | $46.71M | $46.18M | $60.60M | $64.16M |
| Total liabilities | $59.49M | $64.02M | $54.37M | $49.05M | $53.50M | $53.33M | $69.05M | $74.10M |
| Shareholders' equity | $180.28M | $196.38M | $197.68M | $198.92M | $214.71M | $216.00M | $210.96M | $210.11M |
| Shares outstanding | 11.18M | 11.18M | 11.12M | 10.99M | 10.99M | 10.99M | 10.99M | 10.94M |
| Cash flow statement | ||||||||
| Operating cash flow | $3.29M | $1.70M | $260,000 | -$5.28M | $12.11M | -$3.38M | $3.41M | -$4.95M |
| Capital expenditure | $427,000 | $969,000 | $1.10M | $1.35M | $1.36M | $1.38M | $1.52M | $2.29M |
| Free cash flow | $2.87M | $728,000 | -$836,000 | -$6.63M | $10.75M | -$4.76M | $1.88M | -$7.23M |
| Investing cash flow | -$16.82M | -$1.23M | -$17.13M | -$4.95M | -$14.28M | $13.36M | -$2.05M | -$19.43M |
| Financing cash flow | -$11,000 | -$83,000 | -$901,000 | $1,000 | $0 | -$2,000 | -$563,000 | -$1,000 |
| Depreciation & amortization | $2.36M | $3.45M | $3.48M | $3.46M | $3.45M | $4.04M | $3.28M | $3.19M |
| Stock-based compensation | $1.85M | $1.82M | $1.90M | $2.17M | $910,000 | $2.63M | $1.93M | $2.13M |
| Dividends paid | $0 | $83,000 | $87,000 | $0 | $0 | $1,000 | $194,000 | $0 |
| Share buybacks | — | — | — | — | — | — | — | $0 |
Free plan shows the latest 8 periods; Pro shows all 66 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.